Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study

Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study

Jonathan Corren,1 Martin Karpefors,2 Åsa Hellqvist,3 Jane R Parnes,4 Gene Colice5 1Departments of Medicine and Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA; 2Data Science and AI, AstraZeneca, Gothenburg, Sweden; 3Biometrics, Late-Stage Develop...

Full description

Bibliographic Details
Main Authors: Corren J, Karpefors M, Hellqvist Å, Parnes JR, Colice G
Format: Article
Language:English
Published: Dove Medical Press 2021-01-01
Series:Journal of Asthma and Allergy
Subjects:
allergens
asthma
eosinophil
seasonal variation
tezepelumab
thymic stromal lymphopoietin
Online Access:https://www.dovepress.com/tezepelumab-reduces-exacerbations-across-all-seasons-in-patients-with--peer-reviewed-article-JAA

Internet

https://www.dovepress.com/tezepelumab-reduces-exacerbations-across-all-seasons-in-patients-with--peer-reviewed-article-JAA

Similar Items